Kaggen Ausma
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Kaggen Ausma
Chief Business Officer, US Operations from 2021 / PYC Therapeutics
Kaggen Ausma holds double degrees in Law and Economics.
Prior to joining PYC Therapeutics as chief business officer in July 2019, Mr Ausma spent 4 years at McKinsey and Company across Australia, Asia, and the US where he focused on corporate strategy, venture capital, private equity, and technology in many sectors including life sciences. He had also held a role in the economics team at CLSA Asia-Pacific Markets, a sell-side institutional broking firm based in Hong Kong.
Prior to joining PYC Therapeutics as chief business officer in July 2019, Mr Ausma spent 4 years at McKinsey and Company across Australia, Asia, and the US where he focused on corporate strategy, venture capital, private equity, and technology in many sectors including life sciences. He had also held a role in the economics team at CLSA Asia-Pacific Markets, a sell-side institutional broking firm based in Hong Kong.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 367th | Advanced Braking Technology | 23% | 29% |
| 636th | PYC Therapeutics | 3% | 27% |
| 806th | DTI Group | -5% | -15% |
| 1278th | K2fly | -37% | -8% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 87th |  | PYC Therapeutics | $15.8m |
| 90th |  | GreenHy2 | $15.0m |
| 91st | | K2fly | $14.8m |
| 93rd | | Advanced Braking Technology | $14.7m |
| 94th | | DTI Group | $13.3m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Business Analyst, McKinsey & Company | 19 Aug 2020 |
| NEW ROLE: Associate, McKinsey & Company | 19 Aug 2020 |
| NEW ROLE: Engagement Manager, McKinsey & Company | 19 Aug 2020 |
| NEW ROLE: Chief Business Officer, US Operations from 2021, PYC Therapeutics | 19 Aug 2020 |
